title: Limitation of apoptotic changes and crystal deposition by Tutukon following hyperoxaluria-induced tubular cell injury in rat model.
abstract: This study aimed at evaluating the protective effects of a herbal medication (Tutukon) on the hyperoxaluria induced apoptotic changes and crystal deposition in renal tubular epithelium in rat model. 60 male wistar rats were divided into three different groups (each group n: 20). In Group I severe hyperoxaluria was induced by ethylene glycol (EG) (0.75%) administration for 28 days. In Group II, in addition to hyperoxaluria induction, animals were treated with Tutukon for 28 days. Group III animals constituted the controls without any specific medication and/or intervention. While the presence and degree of crystal deposition in the tubular lumen were examined histopathologically under light microscopy, tubular apoptotic changes were evaluated using immunohistochemical staining for cysteine-aspartic acid protease-3 (Caspase-3) and tumor necrosis factor alpha (TNF-α) positivity on days 14 and 28, respectively. Evaluation of apoptotic changes by Caspase-3 positivity showed that while the majority of animals undergoing EG only showed evident apoptotic changes (n: 9), Tutukon application demonstrated a significant limitation with limited or no apoptosis (n: 7) in these animals. Similar data were noted for TNF alpha expression; while apoptotic changes were evident in 8 (80%) in Group I animals, limited changes were noted in Tutukon Group (n: 2). Regarding crystal deposition despite evident changes in Group I (9 animals), like apoptotic alterations, it was again significantly limited in animals receiving Tutukon (4 animals). Renal tubular crystal deposition and apoptotic changes induced by hyperoxaluria play a role in the pathogenesis of urolithiasis and the limitation of these changes might be instituted by Tutukon as a result of its antioxidant and antiinflammatory effects.
authors.affiliation: Department of Urology, Dr. Lutfi Kirdar Kartal Research and Training Hospital, Istanbul, Turkey, cahitsahin129@gmail.com.
authors.forename: Cahit
authors.initials: C
authors.lastname: Sahin
authors.forename: Sukran
authors.initials: S
authors.lastname: Sarikaya
authors.forename: Kayhan
authors.initials: K
authors.lastname: Basak
authors.forename: Cihangir Ali
authors.initials: CA
authors.lastname: Cetinel
authors.forename: Fehmi
authors.initials: F
authors.lastname: Narter
authors.forename: Bilal
authors.initials: B
authors.lastname: Eryildirim
authors.forename: Erkin
authors.initials: E
authors.lastname: Saglam
authors.forename: Kemal
authors.initials: K
authors.lastname: Sarica
mesh_terms: D000818:Animals; D017209:Apoptosis / Q000187:drug effects; D004195:Disease Models, Animal; D004353:Drug Evaluation, Preclinical; D006959:Hyperoxaluria / Q000150:complications / Q000188:drug therapy*; D007684:Kidney Tubules / Q000187:drug effects / Q000378:metabolism; D008297:Male; D008517:Phytotherapy; D010936:Plant Extracts / Q000494:pharmacology / Q000627:therapeutic use*; D017208:Rats, Wistar; D052878:Urolithiasis / Q000209:etiology / Q000517:prevention & control*; D019459:Urothelium / Q000187:drug effects*
chemical_list: D010936:Plant Extracts; C000607527:Tutukon